Corvion
About this raise
Corvion, with a valuation of $56.53 million, is raising funds on StartEngine. It is a pre-clinical medical device company that has developed a next-generation Left Ventricular Assist Device (LVAD). Corvion’s LVAD is ready to disrupt the market and support patients with end-stage heart failure. The LVAD developed by Corvion uses wireless charging and is triple the efficiency of tethered models to free patients from power lines and bulky external systems. Greg Aber founded Corvion in July 2020. The current crowdfunding campaign has a minimum target of $14,999.25 and a maximum target of $1.23 million. The campaign proceeds will be used for product development, company employment, and operating expenses.
Investment Overview
Invested : $800,489
Deal Terms
Total Commitments
- Platform
- StartEngine
- Start Date
- 04/02/2024
- Close Date
- 07/01/2024
$14,999
$1,234,994
$499
Equity - Common
Growth Stage
RegCF
$5.25
$56,529,097
Company & Team
Company
- Year Founded
- 2020
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B2C
- Margin
- High
- Capital Intensity
- High
Financials
- Revenue -59.2% YoY
-
$153,204
as of FY2023
- Monthly Burn
-
$65,000
as of FY2023
-
Runway
-
24+ months
as of
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $22,000,000
- VC Backed?
- No
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 07/01/2024 | StartEngine | $56,529,097 | $800,489 | Equity - Common | Funded | RegCF |